Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 244

1.

Amphotericin B lipid complex in the management of antimony unresponsive Indian visceral leishmaniasis.

Sundar S, Goyal AK, Mandal AK, Makharia MK, Singh VP, Murray HW.

J Assoc Physicians India. 1999 Feb;47(2):186-8.

PMID:
10999086
[PubMed - indexed for MEDLINE]
2.

Treatment of antimony-unresponsive Indian visceral leishmaniasis with ultra-short courses of amphotericin-B-lipid complex.

Sundar S, Goyal AK, More DK, Singh MK, Murray HW.

Ann Trop Med Parasitol. 1998 Oct;92(7):755-64.

PMID:
9924533
[PubMed - indexed for MEDLINE]
3.

Short-course, low-dose amphotericin B lipid complex therapy for visceral leishmaniasis unresponsive to antimony.

Sundar S, Agrawal NK, Sinha PR, Horwith GS, Murray HW.

Ann Intern Med. 1997 Jul 15;127(2):133-7.

PMID:
9230003
[PubMed - indexed for MEDLINE]
4.

Cure of antimony-unresponsive Indian visceral leishmaniasis with amphotericin B lipid complex.

Sundar S, Murray HW.

J Infect Dis. 1996 Mar;173(3):762-5.

PMID:
8627049
[PubMed - indexed for MEDLINE]
Free Article
5.

Short-course, cost-effective treatment with amphotericin B-fat emulsion cures visceral leishmaniasis.

Sundar S, Gupta LB, Rastogi V, Agrawal G, Murray HW.

Trans R Soc Trop Med Hyg. 2000 Mar-Apr;94(2):200-4.

PMID:
10897369
[PubMed - indexed for MEDLINE]
6.

Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients.

López-Vélez R, Videla S, Márquez M, Boix V, Jiménez-Mejías ME, Górgolas M, Arribas JR, Salas A, Laguna F, Sust M, Cañavate C, Alvar J; Spanish HIV-Leishmania Study Group.

J Antimicrob Chemother. 2004 Mar;53(3):540-3. Epub 2004 Jan 22.

PMID:
14739148
[PubMed - indexed for MEDLINE]
Free Article
7.
8.

Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study.

Laguna F, Videla S, Jiménez-Mejías ME, Sirera G, Torre-Cisneros J, Ribera E, Prados D, Clotet B, Sust M, López-Vélez R, Alvar J; Spanish HIV-Leishmania Study Group.

J Antimicrob Chemother. 2003 Sep;52(3):464-8. Epub 2003 Jul 29.

PMID:
12888588
[PubMed - indexed for MEDLINE]
Free Article
9.

Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial.

Subirà M, Martino R, Gómez L, Martí JM, Estany C, Sierra J.

Eur J Haematol. 2004 May;72(5):342-7.

PMID:
15059069
[PubMed - indexed for MEDLINE]
10.

Assessment of nephrotoxicity in patients receiving amphotericin B lipid complex: a pharmacosurveillance study in Spain.

Aguado JM, Lumbreras C, González-Vidal D; Grupo de Farmacovigilancia de Abelcet.

Clin Microbiol Infect. 2004 Sep;10(9):785-90.

PMID:
15355408
[PubMed - indexed for MEDLINE]
11.

Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: a multicenter study.

Sundar S, Jha TK, Thakur CP, Mishra M, Singh VR, Buffels R.

Am J Trop Med Hyg. 2002 Feb;66(2):143-6.

PMID:
12135284
[PubMed - indexed for MEDLINE]
Free Article
12.

Amphotericin B treatment for Indian visceral leishmaniasis: response to 15 daily versus alternate-day infusions.

Sundar S, Chakravarty J, Rai VK, Agrawal N, Singh SP, Chauhan V, Murray HW.

Clin Infect Dis. 2007 Sep 1;45(5):556-61. Epub 2007 Jul 23.

PMID:
17682988
[PubMed - indexed for MEDLINE]
Free Article
13.

New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine.

Sundar S, Rai M, Chakravarty J, Agarwal D, Agrawal N, Vaillant M, Olliaro P, Murray HW.

Clin Infect Dis. 2008 Oct 15;47(8):1000-6. doi: 10.1086/591972.

PMID:
18781879
[PubMed - indexed for MEDLINE]
Free Article
14.

Amphotericin B lipid complex: in visceral leishmaniasis.

Goldsmith DR, Perry CM.

Drugs. 2004;64(17):1905-11; discussion 1912-3. Review.

PMID:
15329037
[PubMed - indexed for MEDLINE]
15.

Amphotericin versus sodium stibogluconate in first-line treatment of Indian kala-azar.

Mishra M, Biswas UK, Jha AM, Khan AB.

Lancet. 1994 Dec 10;344(8937):1599-600.

PMID:
7983993
[PubMed - indexed for MEDLINE]
16.

Assessing the antifungal activity and toxicity profile of amphotericin B lipid complex (ABLC; Abelcet) in combination with caspofungin in experimental systemic aspergillosis.

Sivak O, Bartlett K, Risovic V, Choo E, Marra F, Batty DS Jr, Wasan KM.

J Pharm Sci. 2004 Jun;93(6):1382-9.

PMID:
15124198
[PubMed - indexed for MEDLINE]
17.

Retrospective analysis of the dosage of amphotericin B lipid complex for the treatment of invasive fungal infections.

Linden P, Lee L, Walsh TJ.

Pharmacotherapy. 1999 Nov;19(11):1261-8.

PMID:
10555932
[PubMed - indexed for MEDLINE]
18.

Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompetent patients.

Minodier P, Retornaz K, Horelt A, Garnier JM.

Fundam Clin Pharmacol. 2003 Apr;17(2):183-8. Review.

PMID:
12667228
[PubMed - indexed for MEDLINE]
19.
20.

Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial.

Sundar S, Agrawal G, Rai M, Makharia MK, Murray HW.

BMJ. 2001 Aug 25;323(7310):419-22.

PMID:
11520836
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk